340B Drug Pricing Program
A new opinion piece supported by Arnold Ventures and published in the New England Journal of Medicine is another unfair assault on the only sector in health care that routinely gives back so much more to their communities than they receive in tax relief.
The AHA on Wednesday, July 19 at 3 p.m. ET will host a call to provide member hospitals and health systems with an update on the Centers for Medicare & Medicaid Services’ recent proposed rule that outlines its proposal to remedy hospitals for the agency’s unlawful policy that was unanimously…
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services today issued its proposed remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services (HHS) today issued its proposed remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
After more than five years of litigation and a unanimous Supreme Court victory, the AHA is extremely pleased that 340B hospitals will finally be paid back what they deserve so they can continue providing care to their patients and communities. We are especially gratified that HHS agreed with the…
HHS Issues Proposed Remedy for Its Unlawful 340B Payment Cuts from 2018 to 2022
Register for June 28 Informational Phone Call for 340B Alliance Members On June 28 at 3 p.m. ET.
AHA 340B Advocacy Alliance Bulletin: June 22, 2023.
Louisiana Gov. John Bel Edwards June 19 signed into law state-level protections developed by the AHA. The Louisiana law prevents drug companies from denying, restricting, prohibiting or interfering with the acquisition or delivery of a 340B drug at a contract pharmacy.